NLM Digital Collections

Search

Start Over Subjects Drug Utilization -- trends ✖Remove constraint Subjects: Drug Utilization -- trends Subjects Forecasting ✖Remove constraint Subjects: Forecasting

2. Questionable billing for compounded topical drugs in Medicare Part D

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2018
Subject(s):
Dermatologic Agents -- economics
Dermatologic Agents -- therapeutic use
Drug Compounding -- economics
Drug Utilization -- trends
Fraud
Insurance, Health, Reimbursement
Medicare Part D -- economics
Skin Cream -- economics
Administration, Topical
Dermatologic Agents -- adverse effects
Drug Compounding -- standards
Forecasting
Health Expenditures -- trends
Insurance Coverage
Skin Cream -- adverse effects
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

3. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States

4. Utilization and spending trends in Medicaid outpatient prescription drugs

Author(s):
Young, Katherine, author
Publication:
[San Francisco, California] : Henry J. Kaiser Family Foundation, February 2019
Subject(s):
Drug Utilization -- economics
Drug Utilization -- trends
Health Expenditures -- trends
Medicaid -- economics
Medicaid -- trends
Prescription Drugs -- economics
Drugs, Generic -- economics
Forecasting
Humans
United States